Luminist Capital
PFE icon

Luminist Capital’s Pfizer PFE Stock Holding History

Luminist Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$528K Buy
+18,500
New +$492K 0.53% 32
2026
Q1 		– Sell
-100
Closed -$2.49K – 227
2025
Q4 		$2.49K Buy
100
+25
+33% +$630 ﹤0.01% 208
2025
Q3 		$2.04K Hold
75
– – ﹤0.01% 275
2025
Q2 		$1.88K Buy
+75
New +$1.75K ﹤0.01% 276

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Luminist Capital's PFE Position: Q3 2026 in Review

Luminist Capital opened a new position in Pfizer (PFE) in Q3 2026: 18,500 shares worth $528K. The stake represents 0.53% of the portfolio and ranks #32 among its holdings. This is a return to the name: Luminist Capital previously reported a position in PFE as recently as Q4 2025.

Luminist Capital first reported a position in PFE in Q2 2025 and has held it in 4 quarters since. 1,927 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Luminist Capital held 18,500 shares of Pfizer worth $528K as of Q3 2026.
  • Pfizer was a new Luminist Capital position in Q3 2026.
  • Pfizer made up 0.53% of Luminist Capital's portfolio in Q3 2026, its #32 holding.
  • Luminist Capital first reported a position in Pfizer in Q2 2025 and has held it in 4 quarters since.
  • 1,927 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Luminist Capital's 13F filing for Q3 2026, filed 10 Nov 2026.